MUMBAI, India, April 20 -- Intellectual Property India has published a patent application (202411027145 A) filed by Balwant Rai, Sirsa, Haryana, on Oct. 1, 2024, for 'synergistic nasal formulation with controlled release spray device for allergic rhinitis and other nasal disorders treatment and management.'
Inventor(s) include Balwant Rai.
The application for the patent was published on April 17, under issue no. 16/2026.
According to the abstract released by the Intellectual Property India: "The present invention discloses a novel synergistic nasal formulation comprising hydroxypropyl methylcellulose, xyloglucan, citric acid, and sodium citrate, aimed at providing relief from allergic rhinitis symptoms by moisturizing the nasal mucosa, reducing mucosal irritation, inflammation, and edema. The formulation forms a protective barrier on the nasal mucosa, blocking common allergens and preventing the onset of allergic reactions. Additionally, the invention encompasses a nasal spray device with a guider for controlled release of the formulation, ensuring precise application. The technology offers enhanced efficacy, long-lasting relief, and versatility in formulation, making it suitable for prophylaxis and treatment of allergic disorders of the nasal cavity."
Disclaimer: Curated by HT Syndication.
